t.nardone
TL3 Regular · Tallinn, EE
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 13 October 2024 · last posted 1d
137 posts, newest first. Showing up to 150.
-
The report format the maintainers ask for, and why each field is there Replied, post #5 · marked as the solution · Sourcing › Vendor reports · 26 Jul 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #56 · Analytics › Home & field testing · 25 Jul 2026 · 0 likes I read post #54 twice before replying, because I had assumed the opposite. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An…
-
Common supplements people ask about, assessed one at a time Replied, post #71 · Practice › Interactions · 20 Jul 2026 · 2 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
What a certificate commits its issuer to — one year on Replied, post #110 · Analytics › COA interpretation · 15 Jul 2026 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #20 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #12 · Sourcing › Regulatory · 12 Jul 2026 · 19 likes On post #8 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #17 · Access › Insurance & coverage · 11 Jul 2026 · 32 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #66 · Analytics › Impurities & related substances · 11 Jul 2026 · 0 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Restarting after a long gap: what the labelling implies Replied, post #18 · Practice › Dosing & titration · 9 Jul 2026 · 11 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #31 · Outcomes › Body composition · 26 Jun 2026 · 2 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Personal or family history of medullary thyroid carcinoma Replied, post #4 · Safety › Contraindications · 21 Jun 2026 · 0 likes Picking up the opening post: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently,…
-
Pooling trials with different estimands Replied, post #38 · Evidence › Meta-analyses · 21 Jun 2026 · 1 like post #37 answers the question as asked. The question underneath it is different. Funnel plots: a plot of study effect size versus sample size that helps detect…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #15 · Evidence › Trials · 14 Jun 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #20 · Start Here › Welcome · 13 Jun 2026 · 0 likes Picking up post #17: that is the part I would want checked first. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #96 · Practice › Reconstitution · 8 Jun 2026 · 4 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #16 · Compounds › Secretagogues & GH axis · 2 Jun 2026 · 4 likes Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might impair glucose tolerance. The clinical relevance of…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #27 · Evidence › Journal club · 25 May 2026 · 1 like Picking up post #24: that is the part I would want checked first. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
A single out-of-range value on an otherwise normal panel Replied, post #44 · Clinical › Bloodwork · 9 May 2026 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Analytical imprecision: any measurement has an error margin. A small difference in…
-
Transporting a vial for a weekend away — a second dataset Replied, post #43 · Practice › Storage & stability · 3 May 2026 · 9 likes On post #39 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
A checklist for reading a certificate in under two minutes Replied, post #12 · Analytics › COA interpretation · 28 Apr 2026 · 22 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Managing an unplanned gap in supply Replied, post #109 · Access › Shortages · 24 Apr 2026 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
List price versus negotiated price versus what you pay Replied, post #106 · Access › Pricing · 17 Apr 2026 · 18 likes This follows post #103 rather than contradicting it. Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose,…
-
Spike-and-recover accuracy for a peptide assay Replied, post #43 · Analytics › Method validation · 8 Apr 2026 · 1 like Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
The "under review" status pill and when a moderator applies it Replied, post #54 · Evidence › Preprints · 4 Apr 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #78 · Practice › Interactions · 31 Mar 2026 · 7 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #13 · Analytics › Mass spectrometry · 29 Mar 2026 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Resolution: "high resolution" commonly means
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #4 · Analytics › Mass spectrometry · 11 Mar 2026 · 20 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
The lowest dose that does anything: is that a real question? Replied, post #86 · Practice › Dosing & titration · 7 Mar 2026 · 6 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
The lowest dose that does anything: is that a real question? Replied, post #65 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
What a good consultation looks like from the other side Replied, post #20 · Clinical › Prescriber conversations · 1 Mar 2026 · 1 like Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Cost per delivered dose, which is the number that matters Replied, post #52 · Access › Pricing · 27 Feb 2026 · 0 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #11 · Research Methods › N-of-1 designs · 23 Feb 2026 · 0 likes On post #7 — agreed on the reasoning, with one qualification. When to run an n-of-1: this design works when you want to know whether a treatment works for you, not…
-
Constipation management, with a dietitian's contribution Replied, post #33 · Practice › Side effects · 23 Feb 2026 · 21 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #106 · Clinical › Special populations · 21 Feb 2026 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #30 · Outcomes › Body composition · 20 Feb 2026 · 0 likes On post #26 — agreed on the reasoning, with one qualification. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #28 · Data & Tools › Datasets · 19 Feb 2026 · 0 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #21 · Practice › Dosing & titration · 15 Feb 2026 · 12 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Second pass at: Submitting a sample: the process end to end Replied, post #8 · Sourcing › Independent verification · 14 Feb 2026 · 22 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
[2026 update] What a purity-only report leaves out Replied, post #25 · Sourcing › Independent verification · 14 Feb 2026 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #86 · Documentation › Wiki requests · 13 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #4 · Sourcing › Red flags · 8 Feb 2026 · 23 likes post #3 is right about the mechanism and I think understates the practical bit. Patterns that reliably precede a problem: underdosing (less active material than stated,…
-
Oral semaglutide bioavailability and its variability between people Replied, post #33 · Compounds › Oral incretins · 7 Feb 2026 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #45 · Compounds › Tirzepatide · 7 Feb 2026 · 0 likes On post #41 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #23 · Practice › Reconstitution · 2 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #4 · Analytics › COA interpretation · 29 Jan 2026 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #59 · Documentation › Wiki requests · 28 Jan 2026 · 2 likes post #58 answers the question as asked. The question underneath it is different. Request a new maintained page: if a question recurs, has a good marked solution, and…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #116 · Clinical › Special populations · 27 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #12 · Practice › Administration · 23 Jan 2026 · 9 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #5 · Practice › Administration · 1 Jan 2026 · 4 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #110 · Practice › Side effects · 30 Dec 2025 · 17 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #6 · Outcomes › Body composition · 25 Dec 2025 · 0 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #109 · Compounds › Oral incretins · 24 Dec 2025 · 0 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Waist circumference technique and its repeatability Replied, post #29 · Outcomes › Progress reports · 21 Dec 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Prescription requirements and telehealth models Replied, post #60 · Sourcing › Regulatory · 11 Dec 2025 · 20 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #58 · Compounds › Tirzepatide · 8 Dec 2025 · 10 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #98 · Compounds › Other compounds · 26 Nov 2025 · 1 like Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #36 · Analytics › Impurities & related substances · 21 Nov 2025 · 0 likes post #35 answers the question as asked. The question underneath it is different. Residual solvents: traces of solvents used in purification. These are usually tested by…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #119 · Safety › Adverse events · 11 Nov 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #15 · Sourcing › Regulatory · 29 Oct 2025 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Specification in the result column: why that is a meaningful error Replied, post #61 · Analytics › COA interpretation · 21 Oct 2025 · 20 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Amylin receptor signalling and satiety Replied, post #3 · Pharmacology › Receptor biology · 19 Oct 2025 · 18 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Sleep quality changes during weight loss — what changed since Replied, post #26 · Wellbeing › Sleep · 14 Oct 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #76 · Practice › Storage & stability · 9 Oct 2025 · 8 likes Coming back to post #74, because the follow-up matters more than the original answer. Temperature excursions: if a vial sat at room temperature for a time, the question…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #131 · Practice › Reconstitution · 23 Sep 2025 · 0 likes I read post #129 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #142 · Practice › Storage & stability · 16 Sep 2025 · 0 likes Coming back to post #140, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #136 · Data & Tools › Datasets · 11 Sep 2025 · 20 likes Picking up post #133: that is the part I would want checked first. Limitations of datasets: all community-collected data has limitations. The population is…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #50 · Analytics › HPLC & UHPLC · 28 Aug 2025 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #14 · Analytics › Method validation · 25 Aug 2025 · 12 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Micronutrient status when intake falls substantially Replied, post #24 · Clinical › Bloodwork · 14 Aug 2025 · 6 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #40 · Documentation › Doc review · 13 Aug 2025 · 0 likes This follows post #37 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #23 · Evidence › Journal club · 12 Aug 2025 · 13 likes post #22 is right about the mechanism and I think understates the practical bit. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #112 · Compounds › Semaglutide · 10 Aug 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #90 · Compounds › Semaglutide · 28 Jul 2025 · 10 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Multiplicity when you track fifteen variables Replied, post #2 · Research Methods › Statistics · 24 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #22 · Compounds › Secretagogues & GH axis · 6 Jul 2025 · 25 likes Coming back to post #20, because the follow-up matters more than the original answer. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #8 · Start Here › Welcome · 1 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Repeatability versus intermediate precision Replied, post #61 · Analytics › Method validation · 25 Jun 2025 · 7 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Coming back to: Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 15 Jun 2025 · 24 likes post #29 is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #63 · Practice › Storage & stability · 14 Jun 2025 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Sodium, potassium and magnesium when intake drops Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 12 Jun 2025 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #77 · Outcomes › Body composition · 22 May 2025 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Pregnancy as an absolute contraindication Replied, post #54 · Safety › Contraindications · 19 May 2025 · 13 likes Worth separating two things that post #50 runs together. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute…
-
Appeal templates and why they are deliberately unemotional Replied, post #2 · Access › Insurance & coverage · 13 May 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The C-cell question: rodent findings and their human context Replied, post #15 · Compounds › Semaglutide · 9 May 2025 · 0 likes I read post #13 twice before replying, because I had assumed the opposite. The SELECT trial changed the positioning because it was the first cardiovascular outcome…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #58 · Data & Tools › Calculators · 9 May 2025 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #47 · Data & Tools › Calculators · 3 May 2025 · 0 likes This follows post #44 rather than contradicting it. Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can…
-
[2026 update] US compounding rules and how they changed Replied, post #10 · Regional › North America · 26 Apr 2025 · 15 likes post #9 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Counter-ion content and its effect on measured mass Replied, post #18 · Analytics › Mass spectrometry · 15 Apr 2025 · 21 likes This follows post #15 rather than contradicting it. Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected…
-
Carryover and the ghost peak from last week's standard Replied, post #48 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 13 likes On post #44 — agreed on the reasoning, with one qualification. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #17 · Practice › Administration · 7 Apr 2025 · 11 likes Worth separating two things that post #13 runs together. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh…
-
Retatrutide dose escalation in the published trials Replied, post #93 · Compounds › Retatrutide · 5 Apr 2025 · 12 likes Worth separating two things that post #89 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #8 · Devices › Syringes & needles · 25 Mar 2025 · 1 like Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #121 · Analytics › COA interpretation · 25 Mar 2025 · 8 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #144 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes On post #140 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #10 · Evidence › Trials · 12 Mar 2025 · 27 likes This follows post #7 rather than contradicting it. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #2 · Compounds › Retatrutide · 10 Mar 2025 · 0 likes This follows the opening post rather than contradicting it. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing,…
-
How compounding permissions changed when supply normalised Replied, post #27 · Sourcing › Regulatory · 6 Mar 2025 · 14 likes This follows post #24 rather than contradicting it. Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #23 · Practice › Reconstitution · 27 Feb 2025 · 2 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #19 · Compounds › Semaglutide · 23 Feb 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Validating a method you did not develop — does this still hold? Replied, post #7 · Analytics › Method validation · 13 Feb 2025 · 5 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Consistent declarations and why they matter more than clever ones Replied, post #21 · Sourcing › Logistics · 11 Feb 2025 · 19 likes I read post #19 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #7 · Compounds › Semaglutide · 8 Feb 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
When "no data" is the complete and final answer Replied, post #86 · Compounds › Other compounds · 7 Feb 2025 · 24 likes I read post #84 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Reading a supplementary appendix and finding the interesting part Replied, post #82 · Evidence › Trials · 1 Feb 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Scheduled maintenance and what will be unavailable Replied, post #28 · Meta › Announcements · 29 Jan 2025 · 0 likes This follows post #25 rather than contradicting it. Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #31 · Practice › Dosing & titration · 22 Jan 2025 · 0 likes This follows post #28 rather than contradicting it. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #15 · Practice › Reconstitution · 18 Jan 2025 · 1 like A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Isotonicity and what happens when you get it wrong Replied, post #26 · Pharmacology › Formulation chemistry · 13 Jan 2025 · 0 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
-
Ipamorelin selectivity claims and where they came from Replied, post #6 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 14 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #38 · Compounds › Oral incretins · 10 Jan 2025 · 2 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
Recovery when intake is low: what to cut first Replied, post #10 · Nutrition & Training › Resistance training · 9 Jan 2025 · 18 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Fixed versus detachable needles: the trade-offs Replied, post #100 · Devices › Syringes & needles · 8 Jan 2025 · 2 likes This follows post #97 rather than contradicting it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer).…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #69 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Body image changing more slowly than the body Replied, post #132 · Wellbeing › Mental health · 25 Dec 2024 · 8 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #66 · Evidence › Journal club · 20 Dec 2024 · 1 like SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Coming back to: When to suspect the method rather than the sample Replied, post #97 · Analytics › Method validation · 19 Dec 2024 · 3 likes This follows post #94 rather than contradicting it. Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay…
-
Body image changing more slowly than the body Replied, post #26 · Wellbeing › Mental health · 13 Dec 2024 · 18 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
[2026 update] New subcategory: rationale and scope Replied, post #40 · Meta › Announcements · 3 Dec 2024 · 2 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #28 · Nutrition & Training › Protein & intake · 29 Nov 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why "any advice?" is the least effective ending for a post Replied, post #66 · Start Here › How to Ask · 23 Nov 2024 · 6 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Washout with a one-week half-life: the arithmetic Replied, post #10 · Research Methods › N-of-1 designs · 23 Nov 2024 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Insulin combinations and hypoglycaemia risk Replied, post #3 · Practice › Interactions · 22 Nov 2024 · 15 likes I read the opening post twice before replying, because I had assumed the opposite. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Amylin and gastric emptying: overlapping mechanisms with incretins Started this topic · Compounds › Cagrilintide & amylin analogues · 20 Nov 2024 · 11 likes On the subject in the title: Amylin and gastric emptying: overlapping mechanisms with incretins Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet ,…
-
EMA product information as a primary source — does this still hold? Replied, post #148 · Regional › European Union · 19 Nov 2024 · 10 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #114 · Analytics › COA interpretation · 11 Nov 2024 · 4 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #4 · marked as the solution · Analytics › Mass spectrometry · 7 Nov 2024 · 7 likes Coming back to post #3, because the follow-up matters more than the original answer. Resolution: "high resolution" commonly means
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #54 · Devices › Syringes & needles · 24 Oct 2024 · 14 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Second pass at: Reimbursement variation across member states Replied, post #21 · Regional › European Union · 18 Oct 2024 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
US compounding rules and how they changed Replied, post #8 · Regional › North America · 1 Oct 2024 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #60 · Practice › Dosing & titration · 9 Sep 2024 · 0 likes Worth separating two things that post #56 runs together. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #31 · Sourcing › Independent verification · 2 Sep 2024 · 0 likes Worth separating two things that post #27 runs together. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #39 · Analytics › COA interpretation · 28 Aug 2024 · 13 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #25 · Compounds › Semaglutide · 28 Aug 2024 · 32 likes I read post #23 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #27 · Evidence › Journal club · 27 Aug 2024 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Circumference measurements as a poor man's composition estimate Replied, post #61 · Outcomes › Body composition · 12 Aug 2024 · 8 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Guidelines revision: what changed and why Replied, post #10 · Meta › Announcements · 24 Jul 2024 · 4 likes post #9 is right about the mechanism and I think understates the practical bit. Archives: older announcements are archived by date. Checking archives is useful if you…
-
Assessing a warm arrival: the decision process — one year on Replied, post #114 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…